These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 16311895)

  • 1. MuSK-antibody positive pure ocular myasthenia gravis.
    Hanisch F; Eger K; Zierz S
    J Neurol; 2006 May; 253(5):659-60. PubMed ID: 16311895
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pseudo-internuclear ophthalmoplegia in myasthenia gravis].
    Bogdan I; Crisanda V
    Oftalmologia; 2011; 55(3):70-3. PubMed ID: 22428294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ocular myasthenia: a rare presentation with MuSK antibody and bilateral extraocular muscle atrophy.
    Chan JW; Orrison WW
    Br J Ophthalmol; 2007 Jun; 91(6):842-3. PubMed ID: 17510484
    [No Abstract]   [Full Text] [Related]  

  • 4. Infantile onset myasthenia gravis with MuSK antibodies.
    Murai H; Noda T; Himeno E; Kawano Y; Ohyagi Y; Shiraishi H; Motomura M; Kira J
    Neurology; 2006 Jul; 67(1):174. PubMed ID: 16832105
    [No Abstract]   [Full Text] [Related]  

  • 5. Ocular muscle involvement by myasthenia gravis.
    Kaminski HJ; Ruff RL
    Ann Neurol; 1997 Apr; 41(4):419-20. PubMed ID: 9124796
    [No Abstract]   [Full Text] [Related]  

  • 6. Anti-MuSK myasthenia gravis presenting with purely ocular findings.
    Caress JB; Hunt CH; Batish SD
    Arch Neurol; 2005 Jun; 62(6):1002-3. PubMed ID: 15956173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ocular myasthenia gravis.
    Elrod RD; Weinberg DA
    Ophthalmol Clin North Am; 2004 Sep; 17(3):275-309; v. PubMed ID: 15337189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MRI and clinical studies of facial and bulbar muscle involvement in MuSK antibody-associated myasthenia gravis.
    Farrugia ME; Robson MD; Clover L; Anslow P; Newsom-Davis J; Kennett R; Hilton-Jones D; Matthews PM; Vincent A
    Brain; 2006 Jun; 129(Pt 6):1481-92. PubMed ID: 16672291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early-onset acquired myasthenia gravis secondary to anti-muscle-specific kinase autoantibodies.
    Yilmaz S; Gokben S; Serdaroglu G; Akcay A
    J Child Neurol; 2014 Jan; 29(1):108-10. PubMed ID: 23234677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myasthenia gravis patients with anti-MuSK antibodies.
    Zagar M; Vranjes D; Sostarko M; Vogrinc Z; Bilić E; Trbojević Cepe M
    Coll Antropol; 2009 Dec; 33(4):1151-4. PubMed ID: 20102061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged B-cell depletion in MuSK myasthenia gravis following rituximab treatment.
    Yi JS; Decroos EC; Sanders DB; Weinhold KJ; Guptill JT
    Muscle Nerve; 2013 Dec; 48(6):992-3. PubMed ID: 24006142
    [No Abstract]   [Full Text] [Related]  

  • 12. Two cases of thymoma-associated myasthenia gravis without antibodies to the acetylcholine receptor.
    Maggi L; Andreetta F; Antozzi C; Confalonieri P; Cornelio F; Scaioli V; Mantegazza R
    Neuromuscul Disord; 2008 Aug; 18(8):678-80. PubMed ID: 18657424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maintenance plasma exchange treatment for muscle specific kinase antibody positive myasthenia gravis patients.
    Yamada C; Teener JW; Davenport RD; Cooling L
    J Clin Apher; 2015 Oct; 30(5):314-9. PubMed ID: 25557356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AChR-myasthenia gravis switching to double-seropositive several years after the onset.
    Zouvelou V; Zisimopoulou P; Psimenou E; Matsigkou E; Stamboulis E; Tzartos SJ
    J Neuroimmunol; 2014 Feb; 267(1-2):111-2. PubMed ID: 24388224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mantle cell lymphoma and anti-MuSK-positive Myasthenia gravis.
    Bhatt A; Farooq MU; Chang HT
    Onkologie; 2011; 34(7):382-3. PubMed ID: 21734425
    [No Abstract]   [Full Text] [Related]  

  • 16. [Ocular involvement in MuSK antibody-positive myasthenia gravis].
    Bau V; Hanisch F; Hain B; Zierz S
    Klin Monbl Augenheilkd; 2006 Jan; 223(1):81-3. PubMed ID: 16418940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vocal cord paralysis as a manifestation of myasthenia gravis with anti-MuSK antibodies.
    Jiménez Caballero PE; Fermin Marrero JA; Trigo Bragado I; Casado Naranjo I
    Neurologia; 2014 May; 29(4):253-4. PubMed ID: 23040717
    [No Abstract]   [Full Text] [Related]  

  • 18. Factors associated with insensitivity to pyridostigmine therapy in Thai patients with ocular myasthenia gravis.
    Chirapapaisan N; Tanormrod S; Chuenkongkaew W
    Asian Pac J Allergy Immunol; 2007 Mar; 25(1):13-6. PubMed ID: 17891917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anesthetic Management of a Patient With Antimuscle-Specific Kinase Antibody-Positive Myasthenia Gravis Undergoing an Open Cholecystectomy: A Case Report.
    Akatsu M; Ikegami Y; Tase C; Nishikawa K
    A A Case Rep; 2017 Mar; 8(6):150-153. PubMed ID: 28079665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infantile anti-MuSK positive myasthenia gravis in a patient with autoimmune polyendocrinopathy type 3.
    Duman O; Koken R; Baran RT; Haspolat S; Topaloglu H
    Eur J Paediatr Neurol; 2014 Jul; 18(4):526-8. PubMed ID: 24685514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.